A real time PCR assay for the detection and quantification of orf virus

A real time quantitative PCR assay based on TaqMan ® technology was developed for orf virus (ORFV) DNA quantification in clinical samples, infected cells and organotypic cultures. This method was based on the amplification of a 70 bp fragment from the ORFV B2L gene (orthologue of the Vaccinia virus...

Full description

Saved in:
Bibliographic Details
Published inJournal of virological methods Vol. 134; no. 1; pp. 140 - 145
Main Authors Gallina, L., Dal Pozzo, F., Mc Innes, C.J., Cardeti, G., Guercio, A., Battilani, M., Ciulli, S., Scagliarini, A.
Format Journal Article
LanguageEnglish
Published London Elsevier B.V 01.06.2006
Amsterdam Elsevier
New York, NY
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A real time quantitative PCR assay based on TaqMan ® technology was developed for orf virus (ORFV) DNA quantification in clinical samples, infected cells and organotypic cultures. This method was based on the amplification of a 70 bp fragment from the ORFV B2L gene (orthologue of the Vaccinia virus Copenhagen F13L gene) that encodes the major envelope protein. Both intra- and inter-assay variability were well within ±0.25 log 10 S.D. showing the high efficiency and reproducibility of the assay. The TaqMan ® PCR was subsequently used to determine the titre of several batches of the ORFV strain NZ-2, with it being possible to quantify virus solutions in the range of 1 × 10 1 to 1 × 10 6 TCID 50/ml. A good correlation between the titre determined by the TaqMan ® PCR and by conventional endpoint dilution was found. The PCR assay is reproducible and can be used for a rapid quantification of ORFV in vitro and ex vivo, being readily achievable within 1 h.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0166-0934
1879-0984
DOI:10.1016/j.jviromet.2005.12.014